Does Sea Buckthorn Oil Work for Dry Eyes and Skin? What the Research Shows

Sea buckthorn (Hippophae rhamnoides) has one of the more genuinely interesting evidence profiles on this site - not because the claims are wild, but because the underlying research is unusually easy to misread if you don't know one specific structural detail about the plant itself. Get that detail right, and the rest of the evidence sorts itself out cleanly. This article starts there, and then works through each major claim in turn: dry eyes, where the evidence is genuinely strong; cholesterol, where the picture has shifted meaningfully as better research has arrived; skin and vaginal dryness, where small trials are promising but still need confirmation; and stem cell mobilization, a real published finding that has been stretched considerably further by marketing than the underlying study can support.

A thorny, silvery-leaved shrub that produces small, tart orange berries, sea buckthorn has been used medicinally across Russia, Mongolia, China, and parts of Northern and Central Europe for centuries, valued for treating everything from burns and digestive complaints to respiratory conditions. It has a genuine claim to hardiness that partly explains its nutritional density: it thrives in poor, salt-blasted, high-altitude soil where few other food plants survive, including areas as inhospitable as parts of the Himalayas. That resilience is reflected in the berry's chemistry - it's unusually rich in vitamin C, carotenoids, tocopherols, flavonoids, and, as covered below, an unusual fatty acid profile depending on which part of the plant the oil comes from. None of that resilience-as-metaphor reasoning is itself evidence of anything in humans, but it does help explain why the plant attracted so much traditional and, later, scientific attention in the first place.

Two Oils, One Name: Seed Oil vs. Pulp Oil

Unlike most oil-bearing plants, sea buckthorn produces meaningful oil in two separate places: the seeds and the fruit pulp (the flesh and peel surrounding the seed). These two oils have genuinely different fatty acid compositions, and confusing them is the single most common source of misunderstanding in sea buckthorn marketing - a distinction that turns out to matter for nearly every claim covered in this article, not just one section of it.

The seed itself yields a relatively modest 5-11% of its weight as oil, while the pulp and peel together typically contain 2-20% oil depending on cultivar and ripeness. Both oils are golden-to-deep-orange, thanks to a shared abundance of carotenoids, but chemically they diverge sharply. Seed oil is dominated by two polyunsaturated fatty acids - linoleic acid (omega-6) and alpha-linolenic acid (omega-3) - each typically making up roughly a third of the oil's fatty acid content, a profile broadly similar in spirit to flaxseed or evening primrose oil. Pulp oil is a different substance almost entirely: it's dominated by palmitoleic acid, an omega-7 monounsaturated fatty acid that's genuinely rare in the plant kingdom, together with the saturated fatty acid palmitic acid. Depending on the specific study and cultivar, palmitoleic acid alone can account for 20-42% of pulp oil's total fatty acid content - an extraordinary concentration for a plant source, and part of why sea buckthorn pulp oil is often singled out as one of the very few reliable plant sources of omega-7 at all, alongside macadamia nut oil at meaningfully lower concentrations.

Many commercial products blend the two, and product labels don't always specify the ratio - which matters more than it might seem, because the two oils have been studied for meaningfully different things. A product marketed heavily around "omega-7" is almost certainly leaning on pulp oil or a pulp-enriched blend, while a product marketed around general antioxidant support, tocopherol content, or omega-3/6 balance is more likely seed-oil-dominant. Neither is superior in the abstract - they're simply suited to different goals, and the rest of this article tries to be specific about which oil each piece of evidence actually applies to, rather than treating "sea buckthorn oil" as a single undifferentiated ingredient the way most marketing does.

Dry Eyes: The Best-Documented Use Case

This is sea buckthorn's strongest evidence, and it deserves to be presented clearly, including the one nuance about which oil was actually tested. Dry eye disease is a genuinely common, quality-of-life-degrading condition driven by an unstable, hyperosmolar tear film - the thin layer of fluid and lipid that coats and protects the surface of the eye becomes too concentrated in salts and other solutes relative to normal, which in turn triggers surface inflammation and the classic gritty, burning, foreign-body sensation many people associate with dry eye. Anything that stabilizes that tear film or lowers its osmolarity is a biologically sensible target, and it's exactly what the strongest sea buckthorn trial actually measured.

A separate, smaller trial testing a topical sea buckthorn oil eyelid spray also found meaningful symptom improvement over standard reference sprays, suggesting the effect may not be limited to oral intake alone. That study applied the spray emulsion directly to closed eyelids rather than into the eye itself, on the reasoning that a lipid-containing product resembles the natural composition of the tear film's own oily outer layer more closely than a traditional water-based artificial tear does - a genuinely sensible formulation approach, independent of whether the specific ingredient is sea buckthorn or something else. Taken together, the oral RCT and the smaller topical trial point in a consistent direction: this is one of the more credible, specific, mechanistically coherent claims in the sea buckthorn evidence base, and it holds up well even after accounting for the oil-type nuance above.

Cholesterol and Cardiovascular Risk: A Positive Picture That's Being Walked Back

This is where sea buckthorn's evidence story gets genuinely more complicated, and it's a useful case study in how the most recent, most methodologically careful review can meaningfully change the picture painted by earlier ones - a pattern worth understanding not just for sea buckthorn specifically, but as a general lesson in how to read supplement research over time. Early positive findings tend to get cited for years after a more rigorous follow-up analysis has quietly complicated them, simply because the older, more optimistic papers accumulated more citations and made it into more blog posts and product pages first.

Stem Cell Mobilization: A Real Study, Stretched Well Beyond What It Showed

This is a claim worth addressing directly, because it circulates widely in sea buckthorn marketing and, unlike some of the vaguer traditional claims covered elsewhere on this site, it actually traces back to a specific, real, peer-reviewed human study - which makes it a good test case for the difference between "this happened in a published paper" and "this is a demonstrated health benefit."

Skin and Vaginal Dryness: Promising, Smaller Trials

A 2023 randomized controlled trial gave 40 postmenopausal women (average age 52.5) either sea buckthorn oil capsules or placebo for 12 weeks and found improvements in skin health, along with self-reported satisfaction improvements in dry eye and vaginal dryness symptoms. This tracks with sea buckthorn's traditional use for skin and mucosal complaints and fits the palmitoleic acid mechanism - it closely resembles a component of human sebum, the oily substance your own skin naturally produces to maintain its barrier - but the sample size here is genuinely small, and larger confirmatory trials haven't yet been done.

Vaginal dryness and vulvovaginal atrophy are common, under-discussed symptoms of menopause, driven by declining estrogen and the resulting thinning of vaginal tissue and reduced natural lubrication. Existing treatment options range from topical moisturizers and lubricants to prescription vaginal or systemic estrogen therapy, and a food-based supplement that meaningfully helped would be a genuinely welcome, low-risk addition to that toolkit. The self-reported satisfaction data from the 2023 trial is encouraging in that light, but it's worth being precise about what was actually measured: participant-reported satisfaction on a simple questionnaire, not a validated, clinician-scored severity index of the kind used in the larger hormone-therapy trials for the same symptom. That's not a reason to dismiss the finding, but it is a reason to treat it as an early, promising signal rather than settled evidence, and to keep expectations calibrated to a modest-sample, self-report study rather than a definitive clinical trial.

Separately, sea buckthorn oil and extracts have accumulated a longer track record in wound healing specifically - a 2011 study found that sea buckthorn oil accelerated the repair of skin and mucosal wounds by promoting fibroblast proliferation, the cells responsible for laying down new connective tissue during healing, and topical sea buckthorn preparations have been compared favorably to standard silver sulfadiazine dressings for second-degree burns in at least one small randomized trial. This wound-healing thread is one of the more traditionally consistent uses of the plant across different cultures, and it fits reasonably well with the antioxidant, fibroblast-stimulating, and anti-inflammatory properties documented in laboratory research - though, as with the skin and vaginal dryness data above, the human trials remain small enough that "promising" is a more honest word than "proven."

A Practical Approach

Dosing

What It Stacks Well With